Literature DB >> 8580715

Inflammation in the nervous system.

V H Perry1, M D Bell, H C Brown, M K Matyszak.   

Abstract

Earlier studies on inflammation in the CNS have largely focused on conditions with an immune component. Recent evidence has emerged, however, that the innate, acute inflammatory response in the CNS parenchyma is quite unlike that in other tissues. The meninges and ventricular compartments show more typical responses, as does the parenchyma of the brain in immature animals. It is becoming apparent that the cells of the mononuclear phagocyte lineage dominate inflammatory responses in the CNS parenchyma.

Entities:  

Mesh:

Year:  1995        PMID: 8580715     DOI: 10.1016/0959-4388(95)80069-7

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  45 in total

1.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes.

Authors:  M C Cheeran; G Gekker; S Hu; S L Yager; P K Peterson; J R Lokensgard
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

3.  Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

4.  Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.

Authors:  Ari S Nowacek; JoEllyn McMillan; Reagan Miller; Alec Anderson; Barrett Rabinow; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-17       Impact factor: 4.147

5.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

6.  Macrophages with cellular backpacks for targeted drug delivery to the brain.

Authors:  Natalia L Klyachko; Roberta Polak; Matthew J Haney; Yuling Zhao; Reginaldo J Gomes Neto; Michael C Hill; Alexander V Kabanov; Robert E Cohen; Michael F Rubner; Elena V Batrakova
Journal:  Biomaterials       Date:  2017-06-18       Impact factor: 12.479

7.  Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.

Authors:  Yuling Zhao; Matthew J Haney; Natalia L Klyachko; Shu Li; Stephanie L Booth; Sheila M Higginbotham; Jocelyn Jones; Matthew C Zimmerman; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

8.  Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection.

Authors:  Armen A Galoyan; John S Sarkissian; Vergine A Chavushyan; Ruben M Sulkhanyan; Zaruhi E Avakyan; Zubeida A Avetisyan; Yuri Kh Grigorian; Davit O Abrahamyan
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

Review 9.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

10.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.